Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | LPL | P06858 | 1/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13706143 | 0.94 | HSD17B1 (0.34) | HSD17B1HSD17B2PTGS2 | |
| SCHEMBL13706230 | 0.93 | PDK2 (0.32) | PDK2 | |
| SCHEMBL13706145 | 0.93 | GPR84 (0.33) | PDK2HSD17B1HSD17B2PTGS2 | |
| SCHEMBL24119080 | 0.91 | PDK2 (0.35) | PDK2HSD17B1HSD17B2 | |
| SCHEMBL20102290 | 0.91 | PDK2 (0.33) | PDK2HSD17B1HSD17B2LPLLIPG | |
| SCHEMBL21123722 | 0.90 | PDK2 (0.36) | PDK2HSD17B1HSD17B2ESR1ESR2 | |
| SCHEMBL14070221 | 0.90 | PDK2 (0.36) | PDK2ESR1ESR2 | |
| SCHEMBL25089244 | 0.90 | CA12 (0.34) | PDK2HSD17B1HSD17B2 | |
| SCHEMBL25089256 | 0.90 | CA12 (0.35) | PDK2HSD17B1HSD17B2 | |
| SCHEMBL25546241 | 0.90 | PDK2 (0.32) | PDK2HSD17B1HSD17B2LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OXER1, L1CAM, RPL41 | PDK2 3694/4885HSD17B1 1885/4885HSD17B2 1758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.